Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier-Luc Clermont

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Epigenomics|March 28, 2023
Epigenetics-based diagnostic and therapeutic strategies: shifting the paradigm in prostate cancerPier-Luc Clermont
Epigenomics|September 7, 2017
Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancerPier-Luc Clermont, Lorenzo Fornaro, Francesco Crea
Current Pharmaceutical Design|July 30, 2013
Histone modifications, stem cells and prostate cancerFrancesco Crea, Pier-Luc Clermont, Antonello Mai, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2015
DNA methylation at enhancer regions: Novel avenues for epigenetic biomarker developmentPier-Luc Clermont, Abhijit Parolia, Hui Hsuan Liu, et al.
Cancer Metastasis Reviews|December 19, 2013
The non-coding transcriptome as a dynamic regulator of cancer metastasisFrancesco Crea, Pier Luc Clermont, Abhijit Parolia, et al.
International Journal of Molecular Sciences|January 11, 2019
Development of a Transcriptional Amplification System Based on the PEG3 Promoter to Target Androgen Receptor-Positive and -Negative Prostate Cancer CellsPallavi Jain, Pier-Luc Clermont, Francis Desmeules, et al.
BMC Genomics|April 18, 2013
Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE arrayCharles Vadnais, Arif A Awan, Ryoko Harada, et al.
Epigenomics|September 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editingNing Kang, Mark Eccleston, Pier-Luc Clermont, et al.
International Journal of Cancer|April 11, 2016
Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancersXia Sun, Pier-Luc Clermont, Wenlin Jiao, et al.
Nucleic Acids Research|February 10, 2012
CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damageCharles Vadnais, Sayeh Davoudi, Mojdeh Afshin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Epigenomics|March 28, 2023
Epigenetics-based diagnostic and therapeutic strategies: shifting the paradigm in prostate cancerPier-Luc Clermont
Epigenomics|September 7, 2017
Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancerPier-Luc Clermont, Lorenzo Fornaro, Francesco Crea
Current Pharmaceutical Design|July 30, 2013
Histone modifications, stem cells and prostate cancerFrancesco Crea, Pier-Luc Clermont, Antonello Mai, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2015
DNA methylation at enhancer regions: Novel avenues for epigenetic biomarker developmentPier-Luc Clermont, Abhijit Parolia, Hui Hsuan Liu, et al.
Cancer Metastasis Reviews|December 19, 2013
The non-coding transcriptome as a dynamic regulator of cancer metastasisFrancesco Crea, Pier Luc Clermont, Abhijit Parolia, et al.
International Journal of Molecular Sciences|January 11, 2019
Development of a Transcriptional Amplification System Based on the PEG3 Promoter to Target Androgen Receptor-Positive and -Negative Prostate Cancer CellsPallavi Jain, Pier-Luc Clermont, Francis Desmeules, et al.
BMC Genomics|April 18, 2013
Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE arrayCharles Vadnais, Arif A Awan, Ryoko Harada, et al.
Epigenomics|September 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editingNing Kang, Mark Eccleston, Pier-Luc Clermont, et al.
International Journal of Cancer|April 11, 2016
Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancersXia Sun, Pier-Luc Clermont, Wenlin Jiao, et al.
Nucleic Acids Research|February 10, 2012
CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damageCharles Vadnais, Sayeh Davoudi, Mojdeh Afshin, et al.
Pageof 2